Download PDF
CC BY-NC-ND 4.0 · Planta Med 2021; 87(14): 1192-1205
DOI: 10.1055/a-1578-3803
Biological and Pharmacological Activity
Original Papers

Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System

Deborah Spiess  ‡
1   Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Vanessa Fabienne Abegg‡
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Antoine Chauveau
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Andrea Treyer
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Michael Reinehr
3   Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland
,
Mouhssin Oufir   §
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Elisa Duong
1   Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Olivier Potterat 
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Matthias Hamburger 
2   Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
,
Ana Paula Simões-Wüst 
1   Department of Obstetrics, University Hospital Zurich, University of Zurich, Zurich, Switzerland
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Corrected by:

Correction: Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion SystemPlanta Med eFirst
DOI: 10.1055/a-1666-5352

Retraction

The authors have retracted this paper after they discovered that one of the compounds commercially obtained was in fact another substance. This unfortunate situation was beyond the control of the authors who regret any confusion that may have been caused by the published results.

§ Present address: Oncodesign SA, Villebon-sur-Yvette, France




Publication History

Received: 30 April 2021

Accepted after revision: 28 July 2021

Article published online:
16 September 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany